Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥11.39T | 29.5x | 1.51 | ¥6,922 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.2% Upside | Upgrade to Pro+ | |
Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | ¥7.2T | 29.8x | 0.99 | ¥3,833 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥6.56T | 31.4x | 2.08 | ¥4,137 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.8% Upside | Upgrade to Pro+ | |
Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥4.26T | 28.4x | -1.61 | ¥7,926 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.9% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | ¥2.57T | -44.5x | 1.11 | ¥1,433.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.5% Upside | Upgrade to Pro+ | |
Shionogi | Tokyo | Healthcare | Pharmaceuticals | ¥1.85T | 11x | 0.93 | ¥2,169.50 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.2% Upside | Upgrade to Pro+ | |
Eisai | Tokyo | Healthcare | Pharmaceuticals | ¥1.27T | 31.5x | -2.19 | ¥4,506 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.1% Upside | Upgrade to Pro+ | |
Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | ¥1.11T | 13.4x | 0.31 | ¥2,117 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.7% Upside | Upgrade to Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥721.94B | 9.8x | -0.37 | ¥1,537 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.6% Upside | Upgrade to Pro+ | |
Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥559.05B | 20.5x | -2.61 | ¥2,450.50 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.7% Upside | Upgrade to Pro+ | |
Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥493.25B | 19.8x | 4.12 | ¥1,445 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.9% Upside | Upgrade to Pro+ | |
Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | ¥457.28B | 10x | 0.52 | ¥2,199 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥360.3B | 10.9x | 0.28 | ¥4,661 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.2% Upside | Upgrade to Pro+ | |
Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | ¥328.41B | 13.1x | 0.16 | ¥4,325 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22% Upside | Upgrade to Pro+ | |
Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | ¥308.51B | 20.3x | 1.6 | ¥4,230 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.1% Upside | Upgrade to Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | ¥303.93B | -1.7x | 1.03 | ¥765 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -26.1% Downside | Upgrade to Pro+ | |
Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | ¥263.72B | 15x | -2.8 | ¥4,126 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.3% Upside | Upgrade to Pro+ | |
Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | ¥262.58B | 10.1x | 1.01 | ¥3,897 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.2% Upside | Upgrade to Pro+ | |
Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | ¥224.9B | 10.2x | 0.17 | ¥1,897 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.5% Upside | Upgrade to Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥161B | 8.9x | 0.02 | ¥4,251 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.8% Upside | Upgrade to Pro+ | |
Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥158.81B | 14x | -1.16 | ¥3,710 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥143.2B | 9.1x | 0.07 | ¥2,909 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | |
Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥141.21B | 26.7x | 0.5 | ¥5,030 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.8% Downside | Upgrade to Pro+ | |
Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥118.76B | 26.3x | -1.63 | ¥3,350 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥92.39B | 12.2x | 1.11 | ¥2,096 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | ¥88.37B | -23.5x | 10.33 | ¥983 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | ¥78.88B | 21.2x | -2.14 | ¥1,373 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.3% Downside | Upgrade to Pro+ | |
JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | ¥64.81B | -262.6x | 2.82 | ¥532 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.9% Upside | Upgrade to Pro+ | |
Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | ¥64.47B | 22.7x | -1.35 | ¥1,998 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vital Ksk Holdings | Tokyo | Healthcare | Pharmaceuticals | ¥56.1B | 9.8x | 1.56 | ¥1,162 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | ¥54.52B | 51x | -10.24 | ¥1,922 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.5% Upside | Upgrade to Pro+ | |
Seikagaku Corp | Tokyo | Healthcare | Pharmaceuticals | ¥43.06B | 21.4x | 0.31 | ¥789 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.4% Upside | Upgrade to Pro+ | |
Cuorips | Tokyo | Healthcare | Pharmaceuticals | ¥36.78B | -53.7x | 7.52 | ¥4,590 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuji Pharma Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥33.55B | 5.5x | 0.07 | ¥1,380 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daito Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥31.21B | 11.9x | -0.6 | ¥2,041 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Koa Shoji | Tokyo | Healthcare | Pharmaceuticals | ¥25.9B | 8.3x | 2.8 | ¥615 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuso Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥21.14B | 4.6x | ¥2,498 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
StemRIM | Tokyo | Healthcare | Pharmaceuticals | ¥19.57B | 0.01 | ¥315 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ReproCell | Tokyo | Healthcare | Pharmaceuticals | ¥18.75B | -93.6x | -1.33 | ¥199 | -20.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanBas | Tokyo | Healthcare | Pharmaceuticals | ¥18.1B | -13x | 2.6 | ¥947 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astena Holdings | Tokyo | Healthcare | Pharmaceuticals | ¥17.95B | -7.1x | 0.02 | ¥446 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiko Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥16.31B | -7x | -1.12 | ¥325 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Renascience | Tokyo | Healthcare | Pharmaceuticals | ¥15.42B | -16.3x | -4.01 | ¥1,213 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stella Pharma | Tokyo | Healthcare | Pharmaceuticals | ¥15.15B | -22.7x | -2.71 | ¥445 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncolys Biopharma | Tokyo | Healthcare | Pharmaceuticals | ¥14.17B | -6.1x | 3.02 | ¥570 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CellSeed | Tokyo | Healthcare | Pharmaceuticals | ¥13.76B | -8.8x | ¥397 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ohki Healthcare | Tokyo | Healthcare | Pharmaceuticals | ¥11.58B | 6.2x | -0.21 | ¥849 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Harima-Kyowa | Tokyo | Healthcare | Pharmaceuticals | ¥10.37B | 7.1x | 0.96 | ¥1,926 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Wakamoto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥9.01B | -33.7x | ¥259 | 20.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Perseus Proteomics | Tokyo | Healthcare | Pharmaceuticals | ¥8.81B | -0.55 | ¥598 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |